BELLWETHER BIO INC has a total of 12 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets computer technology, biotechnology and organic fine chemistry are VERINATA HEALTH INC, GREEN CROSS GENOME CORP and GENOMICS COLLABORATIVE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Bioinformatics | |
#3 | Combinatorial chemistry | |
#4 | Healthcare informatics | |
#5 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Snyder Matthew William | 10 |
#2 | Shendure Jay | 6 |
#3 | Azad Robert Navid Farjad | 3 |
#4 | Snyder Matthew | 2 |
#5 | Dean Jason Thaddeus | 2 |
#6 | Dean Jason | 1 |
Publication | Filing date | Title |
---|---|---|
EP3635133A1 | Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints | |
WO2018227211A1 | Diagnosis of cancer or other physiological condition using circulating nucleic acid fragment sentinel endpoints | |
WO2018112100A2 | Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample | |
EP3526350A1 | Determining cell type origin of circulating cell-free dna with molecular counting |